John C. Voris

448 total citations
19 papers, 344 citations indexed

About

John C. Voris is a scholar working on Pharmacology, Geriatrics and Gerontology and Psychiatry and Mental health. According to data from OpenAlex, John C. Voris has authored 19 papers receiving a total of 344 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pharmacology, 5 papers in Geriatrics and Gerontology and 5 papers in Psychiatry and Mental health. Recurrent topics in John C. Voris's work include Pharmaceutical Practices and Patient Outcomes (5 papers), Treatment of Major Depression (4 papers) and Schizophrenia research and treatment (4 papers). John C. Voris is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (5 papers), Treatment of Major Depression (4 papers) and Schizophrenia research and treatment (4 papers). John C. Voris collaborates with scholars based in United States. John C. Voris's co-authors include Lena Al‐Harthi, Alan Landay, Andrea Kovács, Toni Frederick, William M. Glazer, David J. Wright, Marek Nowicki, Eva A. Operskalski, Mary Young and Roksana Karim and has published in prestigious journals such as The Journal of Infectious Diseases, Psychiatric Services and Journal of Clinical Psychology.

In The Last Decade

John C. Voris

19 papers receiving 321 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John C. Voris United States 9 91 76 67 66 61 19 344
Jelena Ivanović Italy 11 48 0.5× 36 0.5× 48 0.7× 109 1.7× 8 0.1× 29 371
Christopher A. Kenedi New Zealand 10 88 1.0× 64 0.8× 114 1.7× 151 2.3× 20 0.3× 15 446
Jerry Snidow United States 10 56 0.6× 59 0.8× 13 0.2× 79 1.2× 7 0.1× 18 432
Federica Alessi Italy 10 59 0.6× 98 1.3× 26 0.4× 189 2.9× 18 0.3× 17 480
Des Jarlais United States 8 482 5.3× 137 1.8× 19 0.3× 343 5.2× 96 1.6× 14 681
R Deutsch United States 7 178 2.0× 241 3.2× 32 0.5× 161 2.4× 32 0.5× 9 537
Jean‐Jacques Déglon Switzerland 10 313 3.4× 36 0.5× 27 0.4× 104 1.6× 152 2.5× 10 611
Sarz Maxwell United States 7 227 2.5× 54 0.7× 103 1.5× 74 1.1× 4 0.1× 8 470
Tony Hebden United States 11 48 0.5× 15 0.2× 130 1.9× 48 0.7× 13 0.2× 27 295
Patricia Pade United States 7 81 0.9× 31 0.4× 15 0.2× 80 1.2× 13 0.2× 9 322

Countries citing papers authored by John C. Voris

Since Specialization
Citations

This map shows the geographic impact of John C. Voris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John C. Voris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John C. Voris more than expected).

Fields of papers citing papers by John C. Voris

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John C. Voris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John C. Voris. The network helps show where John C. Voris may publish in the future.

Co-authorship network of co-authors of John C. Voris

This figure shows the co-authorship network connecting the top 25 collaborators of John C. Voris. A scholar is included among the top collaborators of John C. Voris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John C. Voris. John C. Voris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Kovács, Andrea, Roksana Karim, Wendy J. Mack, et al.. (2010). Activation of CD8 T Cells Predicts Progression of HIV Infection in Women Coinfected with Hepatitis C Virus. The Journal of Infectious Diseases. 201(6). 823–834. 59 indexed citations
2.
Al‐Harthi, Lena, John C. Voris, David J. Wright, et al.. (2006). Evaluating the Impact of Hepatitis C Virus (HCV) on Highly Active Antiretroviral Therapy–Mediated Immune Responses in HCV/HIV‐Coinfected Women: Role of HCV on Expression of Primed/Memory T Cells. The Journal of Infectious Diseases. 193(9). 1202–1210. 43 indexed citations
3.
Al‐Harthi, Lena, John C. Voris, Simone Becker, et al.. (2004). Evaluation of the impact of highly active antiretroviral therapy on immune recovery in antiretroviral naive patients. HIV Medicine. 5(1). 55–65. 31 indexed citations
4.
Voris, John C., et al.. (2003). Assessment of Clinical Pharmacist Management of Lipid-Lowering Therapy in a Primary Care Setting. Journal of Managed Care Pharmacy. 9(3). 269–273. 55 indexed citations
5.
Voris, John C., et al.. (2003). Gabapentin for the Treatment of Ethanol Withdrawal. Substance Abuse. 24(2). 129–132. 51 indexed citations
6.
Voris, John C.. (2003). . Substance Abuse. 24(2). 129–132. 1 indexed citations
7.
Voris, John C., et al.. (2002). Nefazodone in the treatment of patients with post-traumatic stress disorder. Expert Review of Neurotherapeutics. 2(5). 617–623. 1 indexed citations
8.
Voris, John C.. (1999). Trends in the use of selective serotonin reuptake inhibitors in nine department of veterans affairs outpatient facilities. Journal of Clinical Psychology. 55(1). 129–133. 2 indexed citations
9.
Voris, John C. & William M. Glazer. (1999). Best Practices: Use of Risperidone and Olanzapine in Outpatient Clinics at Six Veterans Affairs Hospitals. Psychiatric Services. 50(2). 163–168. 13 indexed citations
10.
Voris, John C., et al.. (1998). Nefazodone: Single versus Twice Daily Dose. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 18(2). 379–380. 3 indexed citations
11.
Voris, John C., et al.. (1998). Money as a tool to extinguish conditioned responses to cocaine in addicts. Journal of Clinical Psychology. 54(2). 211–218. 4 indexed citations
12.
Voris, John C., et al.. (1993). Daily cocaine craving in a 3-week inpatient treatment program. Journal of Clinical Psychology. 49(2). 292–297. 6 indexed citations
13.
Voris, John C., et al.. (1991). A simple test of cocaine craving and related responses. Journal of Clinical Psychology. 47(2). 320–323. 44 indexed citations
14.
Voris, John C., et al.. (1991). Neuroleptic Malignant Syndrome Associated With Carbamazepine. Southern Medical Journal. 84(11). 1378–1380. 12 indexed citations
15.
Voris, John C., et al.. (1988). Development of Pseudomonas Aeruginosa Resistance to Norfloxacin during Therapy. Drug Intelligence & Clinical Pharmacy. 22(10). 773–776. 4 indexed citations
16.
Voris, John C., et al.. (1983). Monitoring Outpatients’ Plasma Antidepressant-Drug Concentrations as a Measure of Compliance. American Journal of Health-System Pharmacy. 40(1). 119–120. 1 indexed citations
17.
Abramson, Ruth K., et al.. (1983). A Rapid High Performance Liquid Chromatographic Method for the Simultaneous Measurement of Six Tricyclic Antidepressants. Journal of Liquid Chromatography. 6(14). 2761–2773. 8 indexed citations
18.
Voris, John C., et al.. (1983). Monitoring outpatients' plasma antidepressant-drug concentrations as a measure of compliance.. PubMed. 40(1). 119–20. 4 indexed citations
19.
Voris, John C., Robert J. Anderson, & Carole L. Kimberlin. (1982). Physician and Pharmacy Student Expectations of Pharmacy Practice. American Journal of Pharmaceutical Education. 46(1). 37–41. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jelena Ivanović Breakdown of academic impact, for papers by Christopher A. Kenedi Breakdown of academic impact, for papers by Jerry Snidow Breakdown of academic impact, for papers by Federica Alessi Breakdown of academic impact, for papers by Des Jarlais Breakdown of academic impact, for papers by R Deutsch Breakdown of academic impact, for papers by Jean‐Jacques Déglon Breakdown of academic impact, for papers by Sarz Maxwell Breakdown of academic impact, for papers by Tony Hebden Breakdown of academic impact, for papers by Patricia Pade
Rankless by CCL
2026